Sandoz Group AG said Europe’s medicines regulator is proposing to pull amoxicillin from its list of critical medicines, a potential death blow to the last European factory to make the antibiotic from scratch.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.